1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > 2013 CRO Quality Benchmarking - Phase II/III Service Providers

2013 CRO Quality Benchmarking - Phase II/III Service Providers

  • April 2013
  • -
  • Industry Standard Research
  • -
  • 248 pages

Summary

Table of Contents

Industry Standard Research’s (ISR) “2013 CRO Quality Benchmarking – Phase II/III Service Providers” report provides pharmaceutical sponsors and clinical service providers with an independent and comprehensive analysis of CRO service quality and clinical outsourcing of Phase II/III clinical trial services.

In its 5th year, ISR continues to believe this annual report is the single most comprehensive source for data on the topic of CRO delivery quality and customer loyalty.

What you will learn in this report:

• Performance of 29 Phase II/III CROs, measured across 26 critical dimensions of service quality
• How sponsors make their clinical outsourcing decisions, including which service attributes drive selection
• Attitudes, beliefs, and intentions for future outsourcing

How you can use this report:

• For buyers of clinical research service, this report offers insight into CRO service quality and empowers you to make smarter clinical outsourcing decisions by providing evaluation and selection tools.
• For clinical service providers, this critical report offers insight into your service quality, your competitors’ quality, buyers’ needs, CRO selection criteria, paths to differentiation, and clinical outsourcing trends and forecasts.

Valuable for:

Clinical Operations, Outsourcing, Service Provider Marketing and Business Development

Characteristics Measured:

Staff Characteristics
• Project Manager Quality / Experience
• CRA Quality / Experience
• Therapeutic Expertise of the Project Team
• Project Team Chemistry
• Timely Project Communications
• Staff Turnover
• Commercial Market Knowledge
• Local Market / Regulatory Knowledge

Operational Excellence
• Up-front Contingency Planning and Trial Risk Management
• Speed of Site Start-up
• Data Quality
• Network of Sites and Investigators
• Meeting Overall Project Timelines
• Meeting Database Lock Timelines
• Meeting First Patient – First Visit Timelines
• Offers Innovative Solutions
• Speed of Sites / Investigator Recruitment
• Patient / Volunteer Recruitment Strategy
• Positive Experience with Service Provider
• Access to Real-time Data

Organizational & Finance Characteristics
• Breadth of Services
• Global Footprint
• Low Cost
• Minimizing Change Orders
• Overall Value
• Financial Strength and Stability

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28500
  • Industry report
  • March 2017
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

  • $ 21100
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2017 Competing in the Global Cancer Diagnostics Market

2017 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.